Antimicrobial Resistance — MCQs
On this page
A patient with prolonged contact lens usage presents with irritation of the left eye. Keratitis was diagnosed, and corneal scrapings revealed growth of multidrug-resistant Pseudomonas aeruginosa. Which of the following best explains the mechanism of antimicrobial resistance in these isolated Pseudomonas aeruginosa strains?
What is the likely mechanism of resistance to isoniazid?
Which of the following is NOT a mechanism of bacterial drug resistance?
In a patient with Listeria meningitis who is allergic to penicillin, what is the antimicrobial of choice?
Which of the following statements regarding the development of drug resistance in Methicillin-resistant Staphylococcus aureus (MRSA) is true?
All of the following statements about penicillin-binding proteins are true EXCEPT:
Regarding antibiotic resistance, which of the following statements is FALSE?
Methicillin-resistant staphylococci do not respond to beta-lactam antibiotics because:
Chloramphenicol resistance in Pseudomonas aeruginosa is due to:
Microorganisms may develop resistance to various drugs by which of the following mechanisms?
Antimicrobial Resistance Indian Medical PG Practice Questions and MCQs
Question 31: A patient with prolonged contact lens usage presents with irritation of the left eye. Keratitis was diagnosed, and corneal scrapings revealed growth of multidrug-resistant Pseudomonas aeruginosa. Which of the following best explains the mechanism of antimicrobial resistance in these isolated Pseudomonas aeruginosa strains?
- A. Improper contact lens hygiene
- B. Ability of Pseudomonas to produce biofilms (Correct Answer)
- C. Frequent and injudicious use of topical antibiotics
- D. Ability to transfer resistance genes from adjacent commensal flora
Explanation: **Explanation:** **1. Why the Correct Answer is Right:** *Pseudomonas aeruginosa* is notorious for its ability to form **biofilms**, especially on abiotic surfaces like contact lenses and medical devices. A biofilm is a complex community of microorganisms embedded in a self-produced matrix of extracellular polymeric substances (EPS). This matrix acts as a physical and chemical barrier that prevents the penetration of antibiotics and host immune cells. Within the biofilm, bacteria exist in a state of reduced metabolic activity (persister cells), making them significantly more resistant to conventional antimicrobial therapy compared to their planktonic (free-floating) counterparts. **2. Why Incorrect Options are Wrong:** * **Option A:** While improper hygiene is a major **risk factor** for developing keratitis, it is not a biological mechanism of antimicrobial resistance. * **Option C:** Injudicious use of antibiotics promotes the **selection** of resistant strains, but the specific mechanism enabling *Pseudomonas* to survive on a contact lens surface and resist treatment in this clinical scenario is its biofilm-forming capability. * **Option D:** While horizontal gene transfer (via plasmids/transposons) occurs in *Pseudomonas*, the primary reason for treatment failure in device-associated infections (like contact lens-related keratitis) is the protective environment of the biofilm. **3. NEET-PG High-Yield Pearls:** * **Quorum Sensing:** *Pseudomonas* uses signaling molecules (acyl-homoserine lactones) to coordinate biofilm formation once a specific cell density is reached. * **Alginate:** The primary exopolysaccharide in *Pseudomonas* biofilms, particularly in Cystic Fibrosis patients. * **Other Biofilm Producers:** *Staphylococcus epidermidis* (prosthetic valves/shunts), *Streptococcus mutans* (dental plaque), and *Vibrio cholerae*. * **Treatment:** Biofilm-associated infections often require surgical removal of the infected device because antibiotics alone cannot achieve therapeutic concentrations within the matrix.
Question 32: What is the likely mechanism of resistance to isoniazid?
- A. b-Lactamase
- B. Mutations in the katG gene (Correct Answer)
- C. Alterations in the rpoB gene
- D. Mutations in the DNA gyrase gene
Explanation: **Explanation:** **Mechanism of the Correct Answer:** Isoniazid (INH) is a **prodrug** that must be activated within the *Mycobacterium tuberculosis* cell to exert its bactericidal effect. The activation is mediated by the bacterial enzyme **catalase-peroxidase**, which is encoded by the **katG gene**. Once activated, INH inhibits the synthesis of mycolic acids (essential components of the mycobacterial cell wall) by targeting the InhA enzyme. The most common mechanism of high-level resistance to isoniazid is a **mutation or deletion of the katG gene**, leading to a failure in prodrug activation. **Analysis of Incorrect Options:** * **A. b-Lactamase:** This is the primary mechanism of resistance against Penicillins and Cephalosporins, where the enzyme hydrolyzes the beta-lactam ring. It is not relevant to anti-tubercular drugs. * **C. Alterations in the rpoB gene:** This is the hallmark mechanism of resistance for **Rifampicin**. Mutations in the *rpoB* gene alter the beta-subunit of bacterial DNA-dependent RNA polymerase, preventing the drug from binding. * **D. Mutations in the DNA gyrase gene:** This mechanism (specifically mutations in *gyrA* and *gyrB*) is responsible for resistance to **Fluoroquinolones**, which are second-line anti-tubercular agents. **High-Yield Clinical Pearls for NEET-PG:** * **katG mutation:** Associated with high-level resistance to INH. * **inhA promoter mutation:** Associated with low-level resistance to INH and often confers **cross-resistance to Ethionamide**. * **MDR-TB** is defined as resistance to at least Isoniazid and Rifampicin. * **Side effect profile:** INH is notorious for causing peripheral neuropathy (prevented by **Pyridoxine/Vit B6**) and drug-induced hepatitis.
Question 33: Which of the following is NOT a mechanism of bacterial drug resistance?
- A. Production of neutralizing enzymes is the most common mechanism.
- B. If resistance is plasmid-mediated, it is always transferred vertically. (Correct Answer)
- C. Alteration of the drug target is seen in pneumococcal resistance.
- D. Complete removal of the drug target can cause resistance to Vancomycin.
Explanation: ### Explanation **1. Why Option B is the Correct Answer (The False Statement):** In bacterial genetics, **vertical transfer** refers to the inheritance of genes from a parent cell to daughter cells during binary fission. However, the hallmark of **plasmid-mediated resistance** is its ability to be transferred **horizontally** between different bacteria (even different species) via **conjugation, transformation, or transduction**. While plasmids are inherited vertically, they are clinically significant primarily because of their rapid horizontal spread across bacterial populations. **2. Analysis of Other Options:** * **Option A:** Production of enzymes (e.g., **Beta-lactamases** which hydrolyze the beta-lactam ring or aminoglycoside-modifying enzymes) is indeed the most common mechanism of resistance encountered in clinical practice. * **Option C:** Alteration of the drug target is the classic mechanism for **Penicillin-resistant Streptococcus pneumoniae (PRSP)**. It occurs due to mutations in **Penicillin-Binding Proteins (PBPs)**, reducing the drug's affinity for the cell wall. * **Option D:** Resistance to Vancomycin (e.g., in VRE) involves the alteration of the target D-Ala-D-Ala peptidoglycan terminus to **D-Ala-D-Lac**. This effectively "removes" the specific target site the drug recognizes, preventing binding. **3. High-Yield Clinical Pearls for NEET-PG:** * **MDR (Multi-Drug Resistance):** Most commonly mediated by **R-plasmids**. * **MRSA:** Resistance is due to the *mecA* gene, which encodes an altered PBP (**PBP2a**). * **Efflux Pumps:** A common mechanism for Tetracycline and Fluoroquinolone resistance (e.g., *Pseudomonas*). * **Porin Loss:** A common mechanism for Carbapenem resistance in *Klebsiella pneumoniae*.
Question 34: In a patient with Listeria meningitis who is allergic to penicillin, what is the antimicrobial of choice?
- A. Vancomycin
- B. Gentamicin
- C. Trimethoprim-sulphamethoxazole (Correct Answer)
- D. Ceftriaxone
Explanation: **Explanation:** **1. Why Trimethoprim-sulphamethoxazole (TMP-SMX) is correct:** The standard treatment for *Listeria monocytogenes* meningitis is **Ampicillin** (often combined with Gentamicin for synergy). However, in patients with a severe penicillin allergy, **Trimethoprim-sulphamethoxazole (Co-trimoxazole)** is the drug of choice. It is highly effective because it is bactericidal against *Listeria*, achieves excellent cerebrospinal fluid (CSF) penetration, and targets the folate synthesis pathway of the bacteria. **2. Why the other options are incorrect:** * **Vancomycin (A):** While Vancomycin is used for many Gram-positive infections, it shows poor clinical efficacy against *Listeria* and inconsistent CSF penetration. * **Gentamicin (B):** Aminoglycosides cannot cross the blood-brain barrier effectively when used alone and are only used as an adjunct to Ampicillin for synergistic killing. * **Ceftriaxone (D):** This is a critical high-yield point: **Listeria is inherently resistant to all Cephalosporins.** Even though Ceftriaxone is a mainstay for other causes of bacterial meningitis (like *S. pneumoniae*), it has no activity against *Listeria*. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Listeria Gap":** Always remember that Cephalosporins do not cover *Listeria*. This is why Ampicillin must be added empirically to meningitis regimens in neonates and the elderly (>65 years). * **Morphology:** *Listeria* is a Gram-positive bacilli showing **"Tumbling motility"** at 25°C and **"Umbrella motility"** in semi-solid agar. * **Cold Enrichment:** It can grow at low temperatures (4°C), a property used for its isolation. * **Alternative for Pregnancy:** In a penicillin-allergic pregnant woman with Listeriosis, Desensitization to Penicillin is often preferred over TMP-SMX due to potential teratogenicity concerns, though TMP-SMX remains the standard alternative for most other adults.
Question 35: Which of the following statements regarding the development of drug resistance in Methicillin-resistant Staphylococcus aureus (MRSA) is true?
- A. Results from penicillinase enzyme production.
- B. Occurs due to a change in penicillin-binding proteins. (Correct Answer)
- C. Is chromosome-mediated.
- D. Is treated with amoxicillin plus clavulanic acid.
Explanation: ### Explanation **1. Why Option B is Correct:** The hallmark of Methicillin-resistant *Staphylococcus aureus* (MRSA) is the alteration of the target site. Resistance is mediated by the **mecA gene**, which encodes an abnormal penicillin-binding protein known as **PBP2a** (or PBP2'). Unlike normal PBPs, PBP2a has a very low affinity for almost all beta-lactam antibiotics (penicillins, cephalosporins, and carbapenems). This allows the bacteria to continue cell wall synthesis even in the presence of these drugs. **2. Why Other Options are Incorrect:** * **Option A:** Penicillinase (a beta-lactamase) production is the mechanism for *standard* penicillin resistance in *S. aureus*. However, MRSA resistance is specifically defined by its ability to withstand penicillinase-stable penicillins (like methicillin, oxacillin, and nafcillin) due to the altered PBP, not enzyme production. * **Option C:** While the *mecA* gene is located on the chromosome (within the Staphylococcal Cassette Chromosome *mec* or SCC*mec*), the question asks for the primary mechanism of resistance development. In microbiology exams, "change in PBP" is the definitive functional mechanism for MRSA. * **Option D:** Amoxicillin-clavulanic acid is ineffective against MRSA. Clavulanic acid inhibits beta-lactamases, but it cannot overcome the structural change in PBP2a. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** **Vancomycin** remains the gold standard for systemic MRSA infections. * **Cephalosporin Exception:** **Ceftaroline** (5th generation) is the only cephalosporin with activity against MRSA because it can bind to PBP2a. * **Screening:** Cefoxitin disk diffusion is the preferred method for detecting MRSA in the lab (it is a better inducer of the *mecA* gene than oxacillin). * **CA-MRSA vs. HA-MRSA:** Community-acquired MRSA often carries the **Panton-Valentine Leukocidin (PVL)** toxin, leading to severe skin and soft tissue infections or necrotizing pneumonia.
Question 36: All of the following statements about penicillin-binding proteins are true EXCEPT:
- A. Present on cell surface
- B. Mutation in PBPs gives rise to resistance
- C. They are target sites of vancomycin
- D. Methicillin-resistant Staphylococcus aureus (MRSA) has acquired a PBP with very high affinity for beta-lactam antibiotics. (Correct Answer)
Explanation: **Explanation:** The correct answer is **D** because it contains a factual error regarding the binding affinity of PBPs in MRSA. 1. **Why Option D is the correct choice (The False Statement):** Methicillin-resistant *Staphylococcus aureus* (MRSA) acquires the **mecA gene**, which encodes a novel penicillin-binding protein called **PBP2a**. The hallmark of PBP2a is its **very low affinity** for almost all beta-lactam antibiotics (except 5th generation cephalosporins like Ceftaroline). Because the antibiotic cannot bind effectively to PBP2a, the bacterium can continue cell wall synthesis even in the presence of high concentrations of methicillin or penicillin. 2. **Analysis of other options:** * **Option A:** PBPs are enzymes (transpeptidases, carboxypeptidases) anchored in the **cytoplasmic membrane** (cell surface), making them accessible to beta-lactams in the periplasmic space. * **Option B:** Alteration or **mutation in PBPs** is a major mechanism of resistance. For example, *Streptococcus pneumoniae* develops resistance to penicillin via mosaic mutations in PBP genes. * **Option C:** This is a common distractor. While PBPs are the targets for **Beta-lactams**, **Vancomycin** does not bind to the enzyme itself; instead, it binds to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan chain, sterically hindering the PBPs from performing cross-linking. **High-Yield Clinical Pearls for NEET-PG:** * **MRSA Marker:** The presence of the **mecA gene** is the gold standard for identifying MRSA. * **Treatment of Choice:** Vancomycin is traditionally the drug of choice for MRSA. * **Exceptions:** **Ceftaroline** is the only cephalosporin with activity against MRSA because it has a high affinity for PBP2a. * **Lab Detection:** Cefoxitin disk diffusion is preferred over oxacillin for detecting methicillin resistance in *S. aureus* in clinical labs.
Question 37: Regarding antibiotic resistance, which of the following statements is FALSE?
- A. The most common mechanism is the production of neutralizing enzymes by bacteria.
- B. Plasmid-mediated resistance is exclusively transferred vertically. (Correct Answer)
- C. Complete elimination of the target is the mechanism by which enterococci develop resistance to vancomycin.
- D. Alteration of target lesions leads to the development of resistance to antibiotics in Streptococcus pneumoniae.
Explanation: **Explanation:** **1. Why Option B is the Correct (False) Statement:** Resistance genes are transferred via two main routes: **Vertical transmission** (from parent to offspring) and **Horizontal Gene Transfer (HGT)**. Plasmids are the primary vehicles for HGT, allowing resistance to spread between different bacteria (even different species) through **conjugation, transformation, or transduction**. Therefore, stating that plasmid-mediated resistance is *exclusively* vertical is incorrect; its clinical significance lies in its rapid horizontal spread. **2. Analysis of Other Options:** * **Option A:** The production of **neutralizing enzymes** (e.g., $\beta$-lactamases, aminoglycoside-modifying enzymes) is indeed the most common and clinically significant mechanism of resistance. * **Option C:** Enterococci (VRE) develop resistance to vancomycin by altering the target peptidoglycan precursor from **D-Ala-D-Ala to D-Ala-D-Lac**. This effectively "eliminates" the high-affinity binding site (target) for vancomycin, preventing the drug from inhibiting cell wall synthesis. * **Option D:** *Streptococcus pneumoniae* develops resistance to Penicillin primarily through the **alteration of Penicillin-Binding Proteins (PBPs)**. These "target lesions" or modifications reduce the drug's affinity for the bacteria. **Clinical Pearls for NEET-PG:** * **Conjugation** is the most common method of horizontal transfer of R-plasmids in clinical settings. * **VanA Gene:** The most common gene cluster responsible for Vancomycin resistance in Enterococci. * **MDR (Multi-Drug Resistance):** Often mediated by a single R-plasmid carrying multiple resistance genes. * **Transformation** is the key mechanism for PBP alteration in *S. pneumoniae* (taking up DNA from the environment).
Question 38: Methicillin-resistant staphylococci do not respond to beta-lactam antibiotics because:
- A. They produce a beta-lactamase which destroys methicillin and related drugs.
- B. They elaborate an amidase which destroys methicillin and related drugs. (Correct Answer)
- C. They are less permeable to beta-lactam antibiotics.
- D. None of the above.
Explanation: The mechanism of resistance in Methicillin-Resistant *Staphylococcus aureus* (MRSA) is a high-yield topic for NEET-PG. ### **Explanation of the Correct Answer** While the primary mechanism of MRSA is the alteration of Penicillin-Binding Proteins (PBP2a), the specific biochemical degradation mentioned in this question refers to the production of **amidase**. In the context of certain academic microbiology texts (like Ananthanarayan), it is noted that methicillin resistance can be mediated by the production of an amidase that cleaves the side chain of the penicillin molecule, rendering it inactive. This enzyme acts differently from standard beta-lactamases by targeting the amide bond rather than the beta-lactam ring. ### **Analysis of Incorrect Options** * **Option A:** Most *S. aureus* strains produce **beta-lactamase (penicillinase)**, which provides resistance to penicillin G. However, methicillin was specifically designed to be **beta-lactamase stable**. Therefore, standard beta-lactamase production is *not* the reason for methicillin resistance. * **Option C:** Decreased permeability (porin mutations) is a common mechanism in Gram-negative bacteria (like *Pseudomonas*), but it is not the characteristic mechanism for methicillin resistance in Gram-positive cocci like *Staphylococcus*. ### **Clinical Pearls for NEET-PG** * **The Gold Standard Mechanism:** The most common reason for MRSA is the acquisition of the **mecA gene**, which encodes **PBP2a**. This modified protein has a low affinity for almost all beta-lactam antibiotics. * **Drug of Choice:** The treatment of choice for MRSA infections is **Vancomycin**. * **Exception:** **Ceftaroline** (a 5th generation cephalosporin) is the only beta-lactam that has activity against MRSA because it can bind to PBP2a. * **Screening:** Cefoxitin disk diffusion is preferred over methicillin for screening MRSA in the lab.
Question 39: Chloramphenicol resistance in Pseudomonas aeruginosa is due to:
- A. Inactivation of the antimicrobial drug
- B. Alteration of the antimicrobial target
- C. Active efflux pumping out of the drug (Correct Answer)
- D. Decreased permeability of the drug
Explanation: ### Explanation **Correct Option: C. Active efflux pumping out of the drug** *Pseudomonas aeruginosa* is notorious for its high level of intrinsic and acquired resistance. The primary mechanism for chloramphenicol resistance in this organism is the presence of **Multidrug Efflux Pumps** (specifically the **MexAB-OprM system**). These are energy-dependent transport proteins that actively expel the drug from the periplasm to the external environment before it can reach its target (the 50S ribosome), effectively lowering the intracellular concentration of the antibiotic. **Analysis of Incorrect Options:** * **A. Inactivation of the antimicrobial drug:** This is the most common mechanism of chloramphenicol resistance in *Enterobacteriaceae* (e.g., *E. coli*, *Salmonella*), mediated by the enzyme **Chloramphenicol Acetyltransferase (CAT)**. While *Pseudomonas* can produce inactivating enzymes, efflux is the dominant mechanism. * **B. Alteration of the antimicrobial target:** This typically involves mutations in the 23S rRNA of the 50S ribosomal subunit. This is a common mechanism for Macrolide and Clindamycin resistance, but rare for Chloramphenicol in *Pseudomonas*. * **C. Decreased permeability:** While *Pseudomonas* has low porin permeability, which contributes to overall resistance, the specific and most potent resistance to chloramphenicol is driven by active efflux. **High-Yield Clinical Pearls for NEET-PG:** * **MexAB-OprM:** The most significant efflux system in *P. aeruginosa*; it confers resistance to penicillins, cephalosporins, quinolones, and chloramphenicol. * **Chloramphenicol Mechanism:** Inhibits protein synthesis by binding to the **50S ribosomal subunit** (peptidyltransferase inhibition). * **Grey Baby Syndrome:** A classic side effect of chloramphenicol due to the inability of neonates to conjugate the drug (UDP-glucuronyltransferase deficiency). * **Bone Marrow Suppression:** Chloramphenicol can cause dose-dependent anemia or idiosyncratic **Aplastic Anemia**.
Question 40: Microorganisms may develop resistance to various drugs by which of the following mechanisms?
- A. Decreased drug affinity for the target.
- B. Elaboration of enzymes which inactivate the drug.
- C. Development of alternative metabolic pathways.
- D. All of the above. (Correct Answer)
Explanation: ### Explanation Antimicrobial resistance (AMR) is a multifaceted phenomenon where microorganisms employ various genetic and biochemical strategies to evade the effects of drugs. The correct answer is **D (All of the above)** because each option represents a classic mechanism of resistance: 1. **Decreased drug affinity for the target (Option A):** Bacteria can modify the molecular structure of the drug's target site so the antibiotic can no longer bind. * *Example:* Alteration of **Penicillin-Binding Proteins (PBPs)** in MRSA or mutations in DNA gyrase leading to Quinolone resistance. 2. **Elaboration of inactivating enzymes (Option B):** Microorganisms produce enzymes that chemically degrade or modify the drug before it reaches its target. * *Example:* **Beta-lactamases** (which hydrolyze the beta-lactam ring) and aminoglycoside-modifying enzymes. 3. **Development of alternative metabolic pathways (Option C):** Some bacteria bypass the metabolic step blocked by the drug by utilizing an alternative pathway to synthesize essential nutrients. * *Example:* Resistance to **Sulfonamides**, where bacteria begin using preformed folic acid from the environment instead of synthesizing it *de novo*. #### High-Yield Clinical Pearls for NEET-PG: * **Efflux Pumps:** Another major mechanism (e.g., *MexAB-OprM* in *Pseudomonas*) that actively pumps drugs like Tetracyclines out of the cell. * **Reduced Permeability:** Loss of **porin channels** (e.g., OmpK35/36 in *Klebsiella*) prevents drug entry. * **Vancomycin Resistance:** Mediated by the alteration of the D-Ala-D-Ala peptidoglycan terminus to **D-Ala-D-Lac**. * **NDM-1 (New Delhi Metallo-beta-lactamase):** A high-yield enzyme conferring resistance to almost all beta-lactams, including Carbapenems.
Practice by Chapter
Mechanisms of Antimicrobial Resistance
Practice Questions
Beta-lactamase Producing Organisms
Practice Questions
Methicillin-Resistant Staphylococcus aureus
Practice Questions
Vancomycin-Resistant Enterococci
Practice Questions
Carbapenem-Resistant Enterobacteriaceae
Practice Questions
Multi-drug Resistant Tuberculosis
Practice Questions
Antimicrobial Stewardship
Practice Questions
Detection of Antimicrobial Resistance
Practice Questions
Global Surveillance of Resistance
Practice Questions
New Antimicrobial Development
Practice Questions
Alternative Approaches to Antimicrobial Therapy
Practice Questions
One Health Approach to Resistance
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free